143 related articles for article (PubMed ID: 37587855)
1. Transcatheter arterial embolization in patients with neuroendocrine neoplasms related to liver metastasis with different blood supplies.
Bai J; Song J; Zhang Y; Li X; Yan L; Hu P; Tang Q
Cancer Med; 2023 Sep; 12(18):18578-18587. PubMed ID: 37587855
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy, prognosis and influencing factors of transcatheter arterial embolization in the treatment of neuroendocrine neoplasm liver metastases].
Zhang Y; Xu RT; Bai JA; Hu P; Li XY; Tian Y; Tang QY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2952-2958. PubMed ID: 37752055
[No Abstract] [Full Text] [Related]
3. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
[TBL] [Abstract][Full Text] [Related]
4. Prolonged progression-free survival achieved by octreotide LAR plus transarterial embolization in low-to-intermediate grade neuroendocrine tumor liver metastases with high hepatic tumor burden.
Liu Y; Liu H; Chen W; Yu H; Yao W; Fan W; Li J; Chen M; Chen J; Wang Y
Cancer Med; 2022 Jul; 11(13):2588-2600. PubMed ID: 35289113
[TBL] [Abstract][Full Text] [Related]
5. Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.
Zhang J; Kulkarni HR; Singh A; Niepsch K; Müller D; Baum RP
J Nucl Med; 2019 Mar; 60(3):377-385. PubMed ID: 30115686
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
7. A comparative study between Embosphere(®) and conventional transcatheter arterial chemoembolization for treatment of unresectable liver metastasis from GIST.
Cao G; Zhu X; Li J; Shen L; Yang R; Chen H; Wang X; Gao S; Xu H; Zhu L; Liu P; Guo J
Chin J Cancer Res; 2014 Feb; 26(1):124-31. PubMed ID: 24653635
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
[TBL] [Abstract][Full Text] [Related]
9. Treatment of symptomatic polycystic liver disease: transcatheter super-selective hepatic arterial embolization using a mixture of NBCA and iodized oil.
Wang MQ; Duan F; Liu FY; Wang ZJ; Song P
Abdom Imaging; 2013 Jun; 38(3):465-73. PubMed ID: 22743841
[TBL] [Abstract][Full Text] [Related]
10. [Role of Imaging in Early Therapeutic Response Assessment for Neuroendocrine Neoplasm with Liver Metastasis:from Anatomical to Functional View].
Gao YH; Wang X; Xue HD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Dec; 43(6):956-961. PubMed ID: 34980337
[TBL] [Abstract][Full Text] [Related]
11. Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study.
Braat AJAT; Bruijnen RCG; van Rooij R; Braat MNGJA; Wessels FJ; van Leeuwaarde RS; van Treijen MJC; de Herder WW; Hofland J; Tesselaar MET; de Jong HWAM; Lam MGEH
Lancet Oncol; 2020 Apr; 21(4):561-570. PubMed ID: 32112737
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
13. Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.
Pericleous M; Caplin ME; Tsochatzis E; Yu D; Morgan-Rowe L; Toumpanakis C
Asia Pac J Clin Oncol; 2016 Mar; 12(1):61-9. PubMed ID: 26663886
[TBL] [Abstract][Full Text] [Related]
14. Transarterial Embolization for Treatment of Symptomatic Polycystic Liver Disease: More than 2-year Follow-up.
Zhang JL; Yuan K; Wang MQ; Yan JY; Xin HN; Wang Y; Liu FY; Bai YH; Wang ZJ; Duan F; Fu JX
Chin Med J (Engl); 2017 Aug; 130(16):1938-1944. PubMed ID: 28776546
[TBL] [Abstract][Full Text] [Related]
15. Correlation of four-phase CT findings of rectal neuroendocrine neoplasms with different World Health Organization grades.
Wang F; Wang J; Li Y; Wang X; Yu D; Zhang X
Abdom Radiol (NY); 2023 Mar; 48(3):855-864. PubMed ID: 36576516
[TBL] [Abstract][Full Text] [Related]
16. Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.
Kankava K; Maisonneuve P; Mangogna A; Centonze G; Cattaneo L; Prinzi N; Pusceddu S; Fazio N; Pisa E; Di Domenico S; Bertani E; Mazzaferro V; Albertelli M; Grillo F; Milione M
J Neuroendocrinol; 2021 Aug; 33(8):e13000. PubMed ID: 34268808
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.
Poleé IN; Hermans BCM; van der Zwan JM; Bouwense SAW; Dercksen MW; Eskens FALM; Havekes B; Hofland J; Kerkhofs TMA; Klümpen HJ; Latten-Jansen LM; Speel EM; Verburg FA; Walenkamp AME; Geurts SME; de Vos-Geelen J
Eur J Cancer; 2022 Sep; 172():252-263. PubMed ID: 35803176
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide Alone or Combined with Capecitabine for the Treatment of Metastatic Neuroendocrine Neoplasia: A "Real-World" Data Analysis.
Bongiovanni A; Liverani C; Foca F; Fausti V; Di Menna G; Mercatali L; De Vita A; Riva N; Calpona S; Miserocchi G; Spadazzi C; Cocchi C; Ibrahim T
Neuroendocrinology; 2021; 111(9):895-906. PubMed ID: 33221806
[TBL] [Abstract][Full Text] [Related]
19. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.
Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
[TBL] [Abstract][Full Text] [Related]
20. Application of embolization microspheres in interventional therapy of malignant non-hypervascular tumor of liver.
Niu H; Du T; Xiao Q; Hu X; Li D; Wang C; Gao W; Xing T; Xu X
Oncotarget; 2017 Aug; 8(33):55593-55599. PubMed ID: 28903446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
